International Summit on Organoid Research and Disease Modeling
ISORDM
Official Invitation Letter Available
An official invitation letter will be provided upon successful registration for your participation in the conference.
Benefits of Registering as Listener
Access to All Conference Sessions
Plenary, keynote and parallel sessions
Networking Opportunities
Connect with global educators & researchers
Certificate of Participation
Digital certificate of participation
Invitation Letter Support
Official invitation letter after successful registration
Conference Kit / Digital Materials
E-proceedings & resource materials
Access to Keynote Sessions
Learn from leading experts & scholars
Conference Session Tracks
Aligned with UN Sustainable Development Goals
The conference's session tracks effectively support the following SDGs.
This session will explore the latest innovations in organoid technology, focusing on the methodologies that enhance the generation and characterization of organoids. Participants will discuss the implications of these advancements for disease modeling and regenerative medicine.
SDG 3
SDG 9
This track will delve into the application of organoid models for understanding the molecular mechanisms underlying various diseases. Researchers will present findings that highlight the relevance of organoids in mimicking disease states and facilitating drug discovery.
SDG 3
SDG 9
This session will focus on the intersection of stem cell science and organoid development, examining how stem cells can be harnessed to create organoids that accurately represent human tissues. Discussions will include techniques for enhancing stem cell differentiation and organoid maturation.
SDG 3
SDG 4
This track will address the translational potential of organoid research in clinical settings, emphasizing how organoids can bridge the gap between laboratory findings and patient care. Case studies will illustrate successful applications in precision medicine and personalized treatment strategies.
SDG 3
SDG 9
This session will highlight the role of organoids in pharmaceutical research, particularly in drug development and toxicity testing. Participants will discuss how organoid systems can provide more predictive models for human responses compared to traditional methods.
SDG 3
SDG 9
This track will explore the ethical implications surrounding organoid research, including issues related to consent, ownership, and the use of human-derived materials. Experts will engage in discussions on establishing ethical frameworks to guide future research.
SDG 16
This session will focus on the integration of organoid technology with tissue engineering approaches to create functional tissue constructs. Researchers will present innovative strategies for combining biomaterials and organoids to advance regenerative medicine.
SDG 3
SDG 9
This track will investigate the utility of organoid models in studying infectious diseases, including viral and bacterial infections. Presentations will cover how organoids can be used to understand pathogen-host interactions and screen for therapeutic agents.
SDG 3
SDG 9
This session will examine the application of organoid models in cancer research, focusing on tumor heterogeneity and treatment resistance. Researchers will discuss how organoids can be utilized to develop and test novel cancer therapies.
SDG 3
SDG 9
This track will explore the role of organoids in advancing precision medicine, particularly in tailoring treatments to individual patients. Discussions will include case studies that demonstrate the effectiveness of organoid-based approaches in clinical decision-making.
SDG 3
SDG 9
This session will provide insights into the future of organoid research, highlighting emerging trends and technologies that could shape the field. Participants will discuss potential breakthroughs and the challenges that lie ahead in translating organoid research into clinical practice.
SDG 3
SDG 9